Skip to main content
Clinical Trials/NCT05531032
NCT05531032
Completed
Not Applicable

Health-related Quality of Life Following Extracorporeal Membrane Oxygenation Due to Coronavirus Disease 2019.

Medical University of Vienna1 site in 1 country44 target enrollmentAugust 30, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ARDS
Sponsor
Medical University of Vienna
Enrollment
44
Locations
1
Primary Endpoint
HRQOL after COVID-19 ARDS and ECMO therapy
Status
Completed
Last Updated
last year

Overview

Brief Summary

We intend to prospectively investigate physical and mental state (HRQOL) by means of quantitative telephone interviews after hospital discharge in patients surviving COVID-19 ARDS and ECMO therapy.

Registry
clinicaltrials.gov
Start Date
August 30, 2022
End Date
October 31, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Martina Hermann

Principal investigator

Medical University of Vienna

Eligibility Criteria

Inclusion Criteria

  • patients surviving COVID-19 ARDS and ECMO therapy

Exclusion Criteria

  • no consent

Outcomes

Primary Outcomes

HRQOL after COVID-19 ARDS and ECMO therapy

Time Frame: 1 year

Health-related quality of life will be delineated by means of a quantitative questionnaire.

Study Sites (1)

Loading locations...

Similar Trials